Luminaring
ADVANCING LONGEVITY RESEARCH AND GENOMICS
At Luminaring, we’re not treating disease. We’re decoding its architecture.
Aging and dysfunction are not just conditions to manage, but patterns to understand, predict, and ultimately reverse.
Through comparative neuroscience, AI, and evolutionary biology, we are advancing longevity research and genomics to decode aging, disease, and human resilience.
Dr. M. Carolina Gallego Iradi, Founder & CSO
Founded by a cross-disciplinary scientist with research experience in neuroscience, immunology, and gene expression analysis, including work at Stanford University, the University of Florida, and the McKnight Brain Institute, Luminaring combines deep academic expertise with a bold approach to innovation.
Why Luminaring Is Different
Decoding Aging, Disease, and Human Resilience
At Luminaring, we believe that uncovering the roots of disease requires more than genetic data alone. It demands a fusion of disciplines. Our approach brings together physics, chemistry, biology, and artificial intelligence to decode complexity at its deepest layers and better understand aging, disease, and human resilience.
We build innovative pipelines that integrate longevity research and genomics with bioinformatics, transcriptomics, and systems biology to accelerate discovery. From pattern recognition to predictive modeling, we turn complex biological signals into meaningful insights.
This integrated approach helps uncover disease-driving mechanisms, identify promising biomarkers, and generate precision medicine insights with real-world relevance. We collaborate with researchers, clinicians, and biotech innovators to translate data into breakthroughs.
Looking to accelerate discovery in longevity research, validate biomarkers, or uncover new disease pathways? Let’s connect.
SCIENTIFIC NETWORK
Collaboration Opportunities
Built on scientific expertise, interdisciplinary relationships, and collaboration readiness
Luminaring is built on a strong scientific foundation shaped by decades of experience, interdisciplinary expertise, and trusted relationships across research, genomics, neuroscience, and translational science. Through a growing network of scientists, domain experts, and innovation ecosystems, we are well positioned to support meaningful collaborations in longevity research, biomarker discovery, and data-driven scientific advancement.
Precision Medicine & Translational Research
Collaboration opportunities with clinicians, medical researchers, and translational teams
Luminaring is well positioned to support precision medicine through genomics, bioinformatics, and translational research. We welcome opportunities to work with clinicians and research teams seeking actionable biological insights, stronger study design, and data-driven discovery.
Neuroscience, Aging & Disease Mechanisms
Interdisciplinary expertise across neuroscience, resilience, and complex disease biology
With deep experience spanning neuroscience, immunology, and gene expression analysis, Luminaring brings a strong foundation to research initiatives focused on aging, cognition, resilience, and disease mechanisms. We are open to collaborations that connect scientific rigor with translational relevance.
Genomics, Bioinformatics & Biomarker Discovery
Partnership opportunities in omics analysis, systems biology, and discovery research
Luminaring integrates longevity research, genomics, bioinformatics, transcriptomics, and systems biology to support discovery-oriented research. Through a strong scientific network and collaboration-ready approach, we are positioned to contribute meaningful analytical support and translational insight.
The Spirit of Discovery
Our Impact: Who Benefits
Biotech Startups Validate hypotheses, structure omics data, and accelerate early-stage discovery without the cost of building everything in-house.
Clinicians & Researchers
Strengthen bioinformatics workflows, uncover molecular mechanisms, and generate more meaningful data-driven insights.
AI & HealthTech Innovators
Enhance models with genomics-informed data, biomarker validation, and pathway-level biological insight.